For tubal/ovarian cancer, the cumulative lifetime risk up to age 80 is 44% for BRCA1 GPV (95% CI: 36–53%) and 17% for BRCA2 GPV (95% CI: 11–25%) [1]. This evidence concerns the gene BRCA2 and ovarian carcinoma.